FDA Registration for Walkers and Mobility Aids

FDA Registration for Walkers and Mobility Aids
FDA Medical Device Guide
Last updated:

FDA Registration for Walkers & Mobility Aids

Yes — walkers and mobility aids are FDA-regulated medical devices requiring Establishment Registration, Device Listing, and annual renewal. Most standard non-wheeled walkers are classified under product code IOR (21 CFR Part 880.5500) as Class II, 510(k) exempt — no premarket submission required. Rollators fall under product code ITZ and are generally also 510(k) exempt. All manufacturers must comply with the QMSR quality system (effective February 2026), UDI labeling, and weight capacity labeling requirements. Annual renewal window: October 1 – December 31 every year.

This guide covers the specific product codes, 510(k) exemption status, QMSR quality system requirements, UDI obligations, weight capacity labeling, ASTM performance standards, and when a walking aid is not a medical device — with everything a manufacturer needs to bring walkers and mobility aids to the U.S. market compliantly.

Classification by Product Type

FDA Classification & 510(k) Status for Walkers and Mobility Aids

The product code determines the classification, applicable special controls, and whether 510(k) premarket notification is required. Confirming the correct product code before Establishment Registration is the essential first step for every mobility aid manufacturer:

Device TypeProduct CodeCFR SectionClass510(k) Required?
Standard walker (non-wheeled, folding, hemi-walker)IOR880.5500Class II510(k) Exempt
Rollator (wheeled walker with brakes and seat)ITZ880.5500Class IIGenerally Exempt
Knee walker / knee scooterIYO880.5500Class IIGenerally Exempt
Medical cane (mobility aid)IOR890.3860Class I / IIGenerally Exempt
Rollator / walker with novel features (motorized, electronic, monitoring)Depends on featuresIndividual reviewClass II510(k) May Be Required
Power mobility scooter / POVMultiple codesIndividual reviewClass IIReview Required
Trekking pole / hiking pole (recreation only)N/AN/ANot a Medical DeviceN/A — if marketed only for outdoor recreation without medical claims
Decorative / fashion cane (no medical claims)N/AN/ANot a Medical DeviceN/A — intended use and labeling determine this; adding medical claims converts it to a device
All Required Compliance Steps

Complete FDA Compliance Requirements for Walker & Mobility Aid Manufacturers

1
Medical Device Establishment Registration — 21 CFR Part 807 Any facility that manufactures, assembles, or processes walkers or mobility aids for U.S. commercial distribution must register as a medical device establishment. Both domestic and foreign manufacturers must register. Foreign manufacturers must designate a U.S. Agent. Annual renewal window: October 1 – December 31 every year — not biennial like food facilities.
2
Device Listing — 21 CFR Part 807 Each individual walker or mobility aid model must be listed with FDA. Device Listing includes the product code, classification, intended use, and manufacturing establishment. Updated whenever new models are introduced, models are discontinued, or device information changes. Failure to list a device is a prohibited act under the FDCA.
3
Quality Management System Regulation (QMSR) — 21 CFR Part 820 Effective February 2, 2026, the QMSR replaced the former QSR and aligns with ISO 13485:2016. Applies to all Class II mobility aid manufacturers including 510(k)-exempt devices. Requirements include design controls, document controls, production and process controls, CAPA, complaints handling, and management review. Manufacturers already certified to ISO 13485:2016 have significant overlap with QMSR but must confirm FDA-specific provisions are satisfied.
4
Device Labeling — 21 CFR Part 801 Labels must include the device's common name; manufacturer/distributor name and address; adequate directions for use; required warnings; and a Unique Device Identifier (UDI). Critical for walkers: maximum weight capacity must be clearly labeled. Absent or inadequate weight capacity labeling is one of the most frequently cited walker labeling violations in FDA inspections. Labels must be in English.
5
Unique Device Identifier (UDI) — 21 CFR Part 830 Class II walker and mobility aid manufacturers have been subject to UDI requirements since September 24, 2016. Each device label must bear a UDI containing a Device Identifier (DI) and Production Identifier (PI). The UDI must also be submitted to FDA's GUDID (Global Unique Device Identification Database) through AccessGUDID before distribution. GUDID submission is separate from Device Listing and both are required.
6
U.S. Agent Designation (Foreign Manufacturers) — 21 CFR Part 807.40 All foreign medical device establishments registered with FDA must designate a U.S. Agent with a physical U.S. address. The U.S. Agent serves as FDA's official domestic contact for the foreign establishment and must assist with inspection coordination and regulatory communications. FDA Registration Assistance provides U.S. Agent services for foreign walker and mobility aid manufacturers.
Key Technical Requirements

QMSR, Performance Standards & Weight Capacity Labeling

QMSR — The 2026 Quality System Update

The Quality Management System Regulation (QMSR), effective February 2, 2026, is the most significant change to FDA's device quality system requirements in decades. The QMSR incorporates ISO 13485:2016 by reference, meaning FDA's quality requirements now directly align with the international standard used in the EU, Canada, Japan, and other major markets. For walker and mobility aid manufacturers:

Already ISO 13485 Certified?

Manufacturers with current ISO 13485:2016 certification will find significant overlap with QMSR. However, FDA-specific provisions — particularly around complaints handling, CAPA, and design controls — must be reviewed for full QMSR compliance. An ISO 13485 certificate is not a substitute for FDA inspectional authority.

Not ISO 13485 Certified?

Manufacturers without ISO 13485 certification must develop a quality management system that meets QMSR requirements. For standard walker manufacturers, the core requirements — design history file, production controls, complaint handling, and CAPA — must be documented and operational before FDA inspection.

ASTM Performance Standards

FDA recognizes two key ASTM consensus standards for walkers and rollators. While conformance is not legally mandated for 510(k)-exempt devices, demonstrating compliance supports quality system documentation and reduces inspection risk:

ASTM F1701

Standard Specification for Non-Wheeled Walkers. Covers static load testing, dynamic stability, fatigue testing, and user instruction requirements for standard and folding walkers. Recommended for manufacturers of product code IOR devices.

ASTM F2380

Standard Specification for Wheeled Walkers (rollators). Covers structural integrity, braking performance, stability, and fatigue testing for rollators. Recommended for manufacturers of product code ITZ devices.

Weight Capacity Labeling — The Most Common Inspection Finding

FDA does not set a universal weight capacity for walkers — but FDA does require that the manufacturer-determined weight capacity be clearly and prominently labeled on every device under 21 CFR Part 801. This is a critical patient safety requirement and is one of the most frequently cited walker compliance violations in FDA inspections:

What FDA Requires

The maximum weight capacity must appear on the device label in a manner that is clear, prominent, and readable. The weight capacity must be based on structural testing of the device. The figure must be accurate — labeling a device as supporting 300 lbs without testing validation is both a labeling and a safety violation.

Common Violations

Absent weight capacity labeling; weight capacity listed only in the instruction manual but not on the device label; weight capacity in non-English units only; or a weight capacity that cannot be substantiated by structural testing documentation in the design history file. All are FDA inspection findings that generate Form 483 observations.

Important Boundary

When Does a Walking Aid Become — or Stop Being — a Medical Device?

Not every product that resembles a walker or cane is an FDA-regulated medical device. The determining factor is intended use as stated in labeling and marketing. A product is a medical device when it is intended to assist with a medical condition, injury recovery, or physical disability. The same physical product can be a medical device or a consumer product depending entirely on how it is marketed:

Medical Device ✓

Walker marketed for post-surgery recovery · Rollator marketed for patients with Parkinson's disease · Cane marketed for people with arthritis or balance disorders · "For use by persons with mobility limitations" · Any product claiming to assist with a medical condition

Context-Dependent

A walking stick marketed both for hiking and for "individuals with balance issues" — the medical use claim makes the entire product a medical device. Once a medical claim is present in any marketing channel (including the website, social media, or Amazon listings), the device classification applies.

Not a Medical Device

Trekking poles marketed only for outdoor recreation · Decorative or fashion canes with no medical claims · Hiking poles marketed only for athletic use · Stage props or costume accessories. If no medical claim is present in any labeling or marketing material, the product is not a medical device.

A company that sells trekking poles for hiking and wants to expand into mobility aids must create a separate, properly registered product line — the hiking product line and the medical device line must have clearly separate labeling and marketing to maintain the non-device status of the recreational product.

Get Registered

Ready to Register Your Walkers or Mobility Aids with FDA?

FDA Registration Assistance handles Medical Device Establishment Registration, Device Listing, U.S. Agent designation, UDI guidance, labeling review including weight capacity compliance, QMSR advisory, and annual renewal management — for walker and mobility aid manufacturers in 135+ countries. 1,000+ clients. 15+ years of FDA regulatory experience.

Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333.

FAQ

Frequently Asked Questions — FDA Registration for Walkers & Mobility Aids

1. Are walkers and mobility aids FDA-regulated medical devices?

Yes. Walkers, rollators, knee walkers, and medical canes intended to assist with mobility limitations are regulated as medical devices under 21 U.S.C. § 360c. Standard non-wheeled walkers are Class II, 510(k) exempt under product code IOR — they require Establishment Registration, Device Listing, and QMSR compliance but not a premarket submission.

2. What is the FDA product code for walkers?

Standard non-wheeled walkers: product code IOR, 21 CFR Part 880.5500, Class II, 510(k) exempt. Rollators: product code ITZ, generally 510(k) exempt. Knee walkers: product code IYO. Confirming the correct product code in FDA's Product Classification Database before any filings is the essential first step.

3. Do standard walkers require a 510(k)?

No. Standard non-wheeled walkers under product code IOR (21 CFR Part 880.5500) are Class II but 510(k) exempt. They require general controls only — Establishment Registration, Device Listing, labeling compliance, and QMSR — without any premarket submission to FDA.

4. Do rollators require a 510(k)?

Most standard rollators under product code ITZ are 510(k) exempt. However, rollators with novel features — motorized assistance, electronic braking, integrated monitoring technology — may require 510(k) if they introduce new safety or effectiveness questions beyond legally marketed predicate devices. Novel features require individual evaluation.

5. What FDA Establishment Registration requirements apply to walker manufacturers?

Any facility manufacturing, assembling, or processing walkers for U.S. distribution must register as a medical device establishment under 21 CFR Part 807. Foreign manufacturers must designate a U.S. Agent. Registration renews annually — October 1 through December 31 every year. This is annual, not biennial like food facility registration.

6. Does each walker model need to be listed with FDA?

Yes. Each individual device model must be listed with FDA under 21 CFR Part 807. Device Listing includes the product code, classification, intended use, and manufacturing establishment. Listings must be updated when new models are introduced or existing device information changes. Failure to list a device is a prohibited act.

7. What is the QMSR and does it apply to walker manufacturers?

Yes. The Quality Management System Regulation (QMSR) — effective February 2, 2026 — replaced the former QSR at 21 CFR Part 820 and aligns with ISO 13485:2016. Applies to all Class II mobility aid manufacturers including 510(k)-exempt devices. Covers design controls, document controls, production controls, CAPA, complaints handling, and management review.

8. Do walkers require Unique Device Identifier (UDI) labeling?

Yes. Class II walkers and mobility aids have been subject to UDI requirements under 21 CFR Part 830 since September 24, 2016. Each device label must bear a UDI. The UDI must also be submitted to FDA's GUDID through AccessGUDID before distribution. GUDID submission is separate from Device Listing and both are required.

9. What labeling is required on walkers and mobility aids?

Under 21 CFR Part 801: device common name; manufacturer/distributor name and address; adequate directions for use; required warnings; maximum weight capacity clearly labeled; and UDI. Labels must be in English. Absent or inadequate weight capacity labeling is the most frequently cited walker labeling violation in FDA inspections.

10. What performance standards apply to walkers and rollators?

FDA recognizes ASTM F1701 for non-wheeled walkers and ASTM F2380 for rollators. These cover static load testing, dynamic stability, fatigue testing, and user instruction requirements. Conformance is not legally mandated for 510(k)-exempt devices but supports quality system documentation and reduces inspection risk.

11. When is a walking aid NOT an FDA-regulated medical device?

When it has no medical intended use in its labeling or marketing. Trekking poles, fashion canes, and hiking poles marketed only for outdoor recreation without any medical claims are not medical devices. Adding any medical use claim — even on a website or social media post — converts the product into a medical device subject to all applicable FDA requirements.

12. How often must Medical Device Establishment Registration be renewed?

Annually — October 1 through December 31 every year. Unlike FDA Food Facility Registration (biennial), medical device establishment registration requires action every single year. Missing the renewal results in inactive registration status affecting the ability to legally market and import devices.

13. What does the U.S. Agent do for a foreign walker manufacturer?

Under 21 CFR Part 807.40, the U.S. Agent must assist FDA with inspection scheduling and coordination, respond to FDA communications, and serve as FDA's official domestic contact for the foreign establishment. FDA Registration Assistance provides U.S. Agent services for foreign walker and mobility aid manufacturers.

14. Can a walker be imported into the U.S. if the manufacturer is not FDA-registered?

No. Walkers from unregistered foreign establishments can be detained or refused at U.S. ports of entry under 21 U.S.C. § 381. Establishment Registration and Device Listing must be complete before any device shipment departs for the United States.

15. What is AccessGUDID and does it apply to walkers?

AccessGUDID is FDA's publicly accessible database where manufacturers submit device identifier information. Class II walker manufacturers must submit device identifier information to GUDID before distributing devices. This is separate from Device Listing and both are required.

16. What is the difference between Class I and Class II for mobility aids?

Class I devices require general controls only. Class II devices require special controls in addition to general controls. Most walkers and rollators are Class II. Many Class II mobility aids are 510(k) exempt — they require general and special controls (including QMSR and UDI) but do not require a premarket submission before marketing.

17. What happens if a mobility aid is marketed without proper FDA registration?

Marketing a device from an unregistered establishment or without Device Listing is a prohibited act under 21 U.S.C. § 331. FDA can issue Warning Letters, refuse device imports, seize devices, seek injunctions, and impose civil penalties.

18. Do electric or motorized mobility scooters have different FDA requirements?

Yes. Power mobility scooters and power-operated vehicles (POVs) are regulated as Class II medical devices with different product codes from standard walkers. Some powered mobility devices may require 510(k) premarket notification depending on their features. FDA Registration Assistance evaluates the specific product code and classification for each motorized mobility device.

19. What are the most common FDA compliance mistakes for walker manufacturers?

Most common: marketing without Establishment Registration and Device Listing; missing the annual October–December renewal; not listing all individual device models; labeling without a UDI; missing or inadequate weight capacity labeling; no QMSR-compliant quality system; foreign manufacturers without a U.S. Agent; and incorrectly assuming 510(k) exemption applies to devices with novel features.

20. Do canes require FDA Establishment Registration?

Yes, when marketed as mobility aids for medical purposes. Medical canes are regulated under 21 CFR Part 890.3860. A fashion or decorative cane with no medical claims is not a medical device. A cane marketed for arthritis, injury recovery, or balance disorders is a medical device requiring Establishment Registration, Device Listing, UDI, and labeling compliance.

21. Does the QMSR change anything for manufacturers already certified to ISO 13485?

ISO 13485:2016-certified manufacturers will find significant overlap with QMSR. However, FDA-specific QMSR provisions — particularly around CAPA, complaints handling, and design controls — must be reviewed for full compliance. An ISO 13485 certificate does not substitute for FDA inspectional authority. QMSR compliance should be confirmed even for ISO-certified manufacturers.

22. Is there a weight limit for walkers regulated by FDA?

FDA does not set a universal weight limit. The manufacturer determines and tests the weight capacity for each model, and that capacity must be clearly labeled on the device under 21 CFR Part 801. The weight capacity must be substantiated by structural testing documentation in the design history file. Inadequate weight capacity labeling is one of the most frequently cited walker labeling violations in FDA inspections.

23. What ASTM standards are recognized by FDA for walkers?

FDA recognizes ASTM F1701 (Standard Specification for Non-Wheeled Walkers) and ASTM F2380 (Standard Specification for Wheeled Walkers/Rollators). Both address structural integrity, stability testing, fatigue testing, and user instructions. Conformance supports QMSR design documentation.

24. Can FDA Registration Assistance handle the full compliance process for walker manufacturers?

Yes. FDA Registration Assistance handles Medical Device Establishment Registration, Device Listing, U.S. Agent designation, UDI guidance, labeling review including weight capacity compliance, QMSR advisory, and annual renewal management. The firm serves 1,000+ clients across 135+ countries with 15+ years of FDA regulatory experience.

25. How do I get started with FDA registration for my walkers or mobility aids?

Contact FDA Registration Assistance at info@fdaregistrationassistance.com or call +1 (928) 275-8333. Provide your device descriptions, manufacturer location, and any existing documentation. FDA Registration Assistance will confirm the product code and classification, determine any 510(k) requirements, and handle Establishment Registration, Device Listing, U.S. Agent designation, UDI guidance, and annual renewal management.

HM
Reviewed By Hector Matos, Senior Regulatory Compliance Specialist  ·  15+ years FDA compliance experience  ·  Published March 2026
Food and Drug Administration Contact Us for Assistance